Literature DB >> 11702289

The epidemiology of parainfluenza virus infection in lung transplant recipients.

R A Vilchez1, K McCurry, J Dauber, A Iacono, R Keenan, A Zeevi, B Griffith, S Kusne.   

Abstract

Human parainfluenza virus (HPIV) is a common cause of seasonal respiratory tract infections. However, little is known about the clinical presentation and impact of HPIV infections in lung transplant recipients. We reviewed HPIV infections at the University of Pittsburgh Medical Center. From January 1990 through May 2000, 32 cases of HPIV infection were identified. HPIV infection was found in 24 lung transplant recipients (75%), all of whom were included in the study group. Diagnosis was established at a median of 2.1 years after transplantation (range, 0.6-5 years). Presenting symptoms included cough (17 patients), shortness of breath (16), and temperature elevation (4). Respiratory failure occurred in 5 patients (21%). The HPIV serotypes were HPIV-1 (7 patients), HPIV-2 (2), and HPIV-3 (15 [63%]). Twenty-two patients underwent transbronchial biopsy, and 18 (82%) showed signs of acute allograft rejection. Seven patients (32%) subsequently were found to have bronchiolitis obliterans.

Entities:  

Mesh:

Year:  2001        PMID: 11702289     DOI: 10.1086/324348

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  25 in total

1.  Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection.

Authors:  Daniel R Goldstein; Bethany M Tesar; Shizuo Akira; Fadi G Lakkis
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 2.  Viral infections in lung transplant recipients.

Authors:  Pali Dedhiya Shah; John F McDyer
Journal:  Semin Respir Crit Care Med       Date:  2010-03-30       Impact factor: 3.119

Review 3.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

Review 4.  Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.

Authors:  Christian Renaud; Angela P Campbell
Journal:  Curr Opin Infect Dis       Date:  2011-08       Impact factor: 4.915

Review 5.  Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation.

Authors:  Ann M Leen; Tamara Tripic; Cliona M Rooney
Journal:  Expert Opin Biol Ther       Date:  2010-03       Impact factor: 4.388

Review 6.  Parainfluenza viruses.

Authors:  Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 7.  Respiratory viruses other than influenza virus: impact and therapeutic advances.

Authors:  W Garrett Nichols; Angela J Peck Campbell; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

8.  Current management of parainfluenza pneumonitis in immunocompromised patients: a review.

Authors:  Ann R Falsey
Journal:  Infect Drug Resist       Date:  2012-08-08       Impact factor: 4.003

9.  Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients.

Authors:  Ronald B Moss; Roy T Steigbigel; Rebecca L Sanders; Fang Fang
Journal:  Adv Virol       Date:  2011-07-07

10.  Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Virus Infections in Lung Transplant Recipients: A Systematic Review of Outcomes and Treatment Strategies.

Authors:  Auke de Zwart; Annelies Riezebos-Brilman; Gerton Lunter; Judith Vonk; Allan R Glanville; Jens Gottlieb; Nitipong Permpalung; Huib Kerstjens; Jan-Willem Alffenaar; Erik Verschuuren
Journal:  Clin Infect Dis       Date:  2022-07-06       Impact factor: 20.999

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.